Skip to main content

Advertisement

Fig. 4 | BMC Neurology

Fig. 4

From: Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)

Fig. 4

Dose of THC:CBD in relation to severity of spasticity. THC:CBD dose was defined as maximum number of THC:CBD actuations per day (mean, maximum and minimum number). Severity of spasticity was assessed by neurologists using a 4-point scale: no spasticity (1 point); mild spasticity (2 points); moderate spasticity (3 points); severe spasticity (4 points). Data are shown for spasticity of the lower extremities. Number of patients = 32

Back to article page